vs
BillionToOne, Inc.（BLLN）与DOMO, INC.（DOMO）财务数据对比。点击上方公司名可切换其他公司
BillionToOne, Inc.的季度营收约是DOMO, INC.的1.1倍（$83.5M vs $79.4M），BillionToOne, Inc.净利率更高（6.8% vs -13.1%，领先19.9%），BillionToOne, Inc.同比增速更快（117.4% vs -0.5%），BillionToOne, Inc.自由现金流更多（$6.5M vs $1.1M）
BillionToOne, Inc.是一家生命科学与分子诊断企业，专注研发高精度基因检测解决方案，核心产品包括无创产前检测、肿瘤诊断试剂及罕见病筛查服务，服务全球多地的医疗机构、患者及科研合作方。
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
BLLN vs DOMO — 直观对比
营收规模更大
BLLN
是对方的1.1倍
$79.4M
营收增速更快
BLLN
高出117.9%
-0.5%
净利率更高
BLLN
高出19.9%
-13.1%
自由现金流更多
BLLN
多$5.4M
$1.1M
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $83.5M | $79.4M |
| 净利润 | $5.7M | $-10.4M |
| 毛利率 | 69.9% | 74.2% |
| 营业利润率 | 11.5% | -8.7% |
| 净利率 | 6.8% | -13.1% |
| 营收同比 | 117.4% | -0.5% |
| 净利润同比 | 138.3% | 44.6% |
| 每股收益（稀释后） | $0.10 | $-0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLLNDOMO
| Q4 25 | — | $79.4M | ||
| Q3 25 | $83.5M | $79.7M | ||
| Q2 25 | — | $80.1M | ||
| Q1 25 | — | $78.8M | ||
| Q4 24 | — | $79.8M | ||
| Q3 24 | $38.4M | $78.4M | ||
| Q2 24 | — | $80.1M | ||
| Q1 24 | — | $80.2M |
净利润BLLNDOMO
| Q4 25 | — | $-10.4M | ||
| Q3 25 | $5.7M | $-22.9M | ||
| Q2 25 | — | $-18.1M | ||
| Q1 25 | — | $-17.7M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $-14.9M | $-19.5M | ||
| Q2 24 | — | $-26.0M | ||
| Q1 24 | — | $-18.7M |
毛利率BLLNDOMO
| Q4 25 | — | 74.2% | ||
| Q3 25 | 69.9% | 74.8% | ||
| Q2 25 | — | 74.2% | ||
| Q1 25 | — | 74.4% | ||
| Q4 24 | — | 75.0% | ||
| Q3 24 | 52.6% | 74.3% | ||
| Q2 24 | — | 74.1% | ||
| Q1 24 | — | 76.3% |
营业利润率BLLNDOMO
| Q4 25 | — | -8.7% | ||
| Q3 25 | 11.5% | -9.1% | ||
| Q2 25 | — | -17.9% | ||
| Q1 25 | — | -15.6% | ||
| Q4 24 | — | -13.9% | ||
| Q3 24 | -32.9% | -18.5% | ||
| Q2 24 | — | -26.8% | ||
| Q1 24 | — | -16.6% |
净利率BLLNDOMO
| Q4 25 | — | -13.1% | ||
| Q3 25 | 6.8% | -28.8% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -22.4% | ||
| Q4 24 | — | -23.5% | ||
| Q3 24 | -38.8% | -24.9% | ||
| Q2 24 | — | -32.5% | ||
| Q1 24 | — | -23.3% |
每股收益（稀释后）BLLNDOMO
| Q4 25 | — | $-0.25 | ||
| Q3 25 | $0.10 | $-0.56 | ||
| Q2 25 | — | $-0.45 | ||
| Q1 25 | — | $-0.45 | ||
| Q4 24 | — | $-0.48 | ||
| Q3 24 | $-1.47 | $-0.51 | ||
| Q2 24 | — | $-0.69 | ||
| Q1 24 | — | $-0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.2M | — |
| 总债务越低越好 | $55.0M | $124.2M |
| 股东权益账面价值 | $-239.5M | $-191.9M |
| 总资产 | $327.5M | $201.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BLLNDOMO
| Q4 25 | — | — | ||
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | $47.2M | ||
| Q1 25 | — | $45.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $61.2M | ||
| Q1 24 | — | $60.9M |
总债务BLLNDOMO
| Q4 25 | — | $124.2M | ||
| Q3 25 | $55.0M | $121.9M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $117.7M | ||
| Q4 24 | — | $115.6M | ||
| Q3 24 | — | $115.2M | ||
| Q2 24 | — | $114.1M | ||
| Q1 24 | — | $113.5M |
股东权益BLLNDOMO
| Q4 25 | — | $-191.9M | ||
| Q3 25 | $-239.5M | $-191.5M | ||
| Q2 25 | — | $-178.7M | ||
| Q1 25 | — | $-177.2M | ||
| Q4 24 | — | $-171.2M | ||
| Q3 24 | $-242.9M | $-166.4M | ||
| Q2 24 | — | $-163.5M | ||
| Q1 24 | — | $-153.5M |
总资产BLLNDOMO
| Q4 25 | — | $201.6M | ||
| Q3 25 | $327.5M | $195.7M | ||
| Q2 25 | — | $189.7M | ||
| Q1 25 | — | $214.3M | ||
| Q4 24 | — | $190.2M | ||
| Q3 24 | — | $197.8M | ||
| Q2 24 | — | $204.4M | ||
| Q1 24 | — | $225.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $3.4M |
| 自由现金流经营现金流 - 资本支出 | $6.5M | $1.1M |
| 自由现金流率自由现金流/营收 | 7.7% | 1.4% |
| 资本支出强度资本支出/营收 | 8.8% | 2.9% |
| 现金转化率经营现金流/净利润 | 2.42× | — |
| 过去12个月自由现金流最近4个季度 | — | $9.9M |
8季度趋势，按日历期对齐
经营现金流BLLNDOMO
| Q4 25 | — | $3.4M | ||
| Q3 25 | $13.8M | $3.4M | ||
| Q2 25 | — | $4.0M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | — | $-13.7M | ||
| Q3 24 | — | $-6.2M | ||
| Q2 24 | — | $1.9M | ||
| Q1 24 | — | $5.4M |
自由现金流BLLNDOMO
| Q4 25 | — | $1.1M | ||
| Q3 25 | $6.5M | $1.0M | ||
| Q2 25 | — | $1.0M | ||
| Q1 25 | — | $6.7M | ||
| Q4 24 | — | $-16.2M | ||
| Q3 24 | — | $-8.4M | ||
| Q2 24 | — | $-625.0K | ||
| Q1 24 | — | $2.9M |
自由现金流率BLLNDOMO
| Q4 25 | — | 1.4% | ||
| Q3 25 | 7.7% | 1.3% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 8.5% | ||
| Q4 24 | — | -20.3% | ||
| Q3 24 | — | -10.7% | ||
| Q2 24 | — | -0.8% | ||
| Q1 24 | — | 3.6% |
资本支出强度BLLNDOMO
| Q4 25 | — | 2.9% | ||
| Q3 25 | 8.8% | 2.9% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 3.1% |
现金转化率BLLNDOMO
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
